Apiform Laboratories Private Limited
About Apiform Laboratories Private Limited
Data last updated:
Apiform Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC138106. Its GSTIN is 36AATCA1214A1Z6 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nikhil Teja Reddy Mandha and Pooja Reddy Konda Reddy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No.8 – 2 – 293/82/A/141 Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.96 Lakh. For the same year it recorded a net profit of ₹1.77 Lakh (net margin 90.3%) and EBITDA of ₹1.77 Lakh (EBITDA margin 90.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No.8 – 2 – 293/82/A/141 Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Apiform Laboratories Private Limited
The main business activity of Apiform Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apiform Laboratories Private Limited FY 2025 filings available
Apiform Laboratories Private Limited reported revenue of ₹1.96 Lakh for FY 2024.
Financial Statement Summary of Apiform Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.77 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.77 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apiform Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 90.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 90.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apiform Laboratories are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Apiform Laboratories Private Limited
Apiform Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Venkateshwara Aromatics Private Limited | ₹1.97 Lakh (FY 2025) | •••• | •••• | 74.0% | •••• | Pune, Maharashtra, India |
| Carya Chemicals & Fertilizers Private Limited | ₹1.97 Lakh (FY 2025) | •••• | •••• | -95.0% | •••• | New Delhi, Delhi, India |
| Achetpa (OPC) Private Limited | ₹1.97 Lakh (FY 2025) | •••• | •••• | 1181.0% | •••• | Imphalwest, Manipur, India |
| Trans Molecules Pharma Private Limited | ₹1.96 Lakh (FY 2018) | •••• | •••• | -48.0% | •••• | Mandi, Himachal Pradesh, India |
| Apiform Laboratories Private Limited this company | ₹1.96 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Vallark Pharma Private Limited | ₹1.96 Lakh (FY 2025) | •••• | •••• | -65.0% | •••• | Hyderabad, Telangana, India |
| Vilohit Care Tek Solutions Private Limited | ₹1.96 Lakh (FY 2025) | •••• | •••• | •••• | Udupi, Karnataka, India | |
| Jivabio Mineral and Fertilizers Private Limited | ₹1.96 Lakh (FY 2022) | •••• | •••• | -50.0% | •••• | Ujjain, Madhya Pradesh, India |
| Amrete Healthcare (India) Private Limited | ₹1.96 Lakh (FY 2024) | •••• | •••• | 55719.0% | •••• | Mumbai, Maharashtra, India |
| Gajanand Herbal Private Limited | ₹1.96 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Gwalior, Madhya Pradesh, India |
| TSC Chemequip Private Limited | ₹1.95 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Apiform Laboratories by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Apiform Laboratories Private Limited
Apiform Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Teja Reddy Mandha Also directs: Organozen Chemicals Private Limited, Enal Drugs Pvt Ltd., Apichem Laboratories Private Limited and 2 more | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Pooja Reddy Konda Reddy | Additional Director | 31 May 2025 | 1 Years 4 Months | Current |
Ownership and Shareholding of Apiform Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apiform Laboratories Private Limited
Apiform Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Apiform Laboratories Private Limited
Employment history and EPFO contributions of people linked to Apiform Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Apiform Laboratories Private Limited
Apiform Laboratories Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Achyuth Reddy Manne ceased to be Director on 01 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for Apiform Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apiform Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apiform Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apiform Laboratories Private Limited
Apiform Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA1214A1Z6 | Telangana | Active | 25 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apiform Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apiform Laboratories Private Limited
Apiform Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U24239TG2019PTC138106.
Apiform Laboratories reported revenue of ₹1.96 Lakh for FY 2024.
Apiform Laboratories has 2 current directors:
- Nikhil Teja Reddy Mandha - Director
- Pooja Reddy Konda Reddy - Additional Director
Apiform Laboratories reported a net profit of ₹1.77 Lakh (net margin 90.3%) and EBITDA of ₹1.77 Lakh (EBITDA margin 90.3%) for FY 2024, as per its filed financial statements.
The GSTIN of Apiform Laboratories is 36AATCA1214A1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Apiform Laboratories is U24239TG2019PTC138106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apiform Laboratories was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Apiform Laboratories by revenue are Venkateshwara Aromatics Private Limited, Carya Chemicals & Fertilizers Private Limited, Achetpa (OPC) Private Limited, Trans Molecules Pharma Private Limited, Vallark Pharma Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Achyuth Reddy Manne ceased to be Director on 01 Jun 2025. Pooja Reddy Konda Reddy was appointed as Additional Director on 31 May 2025. Nikhil Teja Reddy Mandha was appointed as Director on 31 Dec 2019.
The registered office of Apiform Laboratories is at H. No.8 – 2 – 29382A141 Road No.10 Jubilee Hills, Hyderabad, Telangana, India – 500033.
Apiform Laboratories has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.